Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898804 · ClinicalTrials.gov registry record · NA
An Early Feasibility Study of the ReHAB System
A NA study of Tetraplegia, sponsored by Jennifer Sweet, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03898804: Recruiting NA study of Tetraplegia, sponsored by Jennifer Sweet, MD.
NCT03898804 is a NA study of Tetraplegia that is actively recruiting participants, run by Jennifer Sweet, MD. The registered enrollment target is 12 participants, below the 19-participant average among 23 other Tetraplegia trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03898804, a NA study of Tetraplegia, is actively recruiting participants, sponsored by Jennifer Sweet, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to examine the feasibility of a system that involves implanting small electrodes in the parts of the brain that control movement and sensation, and combining that with electrodes in the upper arm and shoulder to activate paralyzed muscles of the arm and hand. This system is intended for people with extensive paralysis in their arms. The small electrodes in the brain will be used to attempt to measure intended movements, and the muscles in the arm and hand will be stimulated to attempt to follow those intentions. The study is a prospective, non-randomized, open-label, exploratory safety/feasibility trial of up to 12 subjects. The Primary Endpoint will be evaluation over the first 13 months after implantation, after which the subjects will have the option of removal of the device or continued participation in a long-term study.
Primary Outcome
Successful implantation of brain and extremity recording/stimulating electrodes for 1 year without explantation or device-related serious adverse events.
Conditions Studied
Interventions
- DEVICE BCI and FES
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT03898804 shows while recruiting
NCT03898804 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 19-participant average among 23 other Tetraplegia trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Tetraplegia appearing as the primary indexed condition, and to 1 intervention - of which BCI and FES is the first listed.
NCT03898804 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03898804 about?
NCT03898804 is a clinical study titled "An Early Feasibility Study of the ReHAB System". The purpose of this research study is to examine the feasibility of a system that involves implanting small electrodes in the parts of the brain that control movement and sensation, and combining that with electrodes in the upper arm and shoulder to activate paralyzed muscles of the arm and hand. Th...
What is the current status of trial NCT03898804?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2019-04-09. Estimated completion is 2027-03-01.
What conditions does trial NCT03898804 study?
This clinical trial studies the following conditions: Tetraplegia.
What interventions are being tested in trial NCT03898804?
The interventions under investigation include: BCI and FES (DEVICE).
Who is sponsoring clinical trial NCT03898804?
This trial is sponsored by Jennifer Sweet, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03898804 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetraplegia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03898804's enrollment target sits among peer trials
12 12th of 23 higher than 11 of 23 other Tetraplegia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tetraplegia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Evaluation of an Advanced Lower Extremity Neuroprostheses
RECRUITING · NA
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
-
Investigation on the Cortical Communication (CortiCom) System
RECRUITING · NA
-
A Neuroprosthesis for Seated Posture and Balance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI